Skip to product information
1 of 2

Flt-3/Flk-2 Fc Chimera Protein, Cynomolgus

Flt-3/Flk-2 Fc Chimera Protein, Cynomolgus

Catalog Number: UA040549 Brand: UA BIOSCIENCE
Price:
Regular price $115 USD
Regular price Sale price $115 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Cynomolgus
Synonyms Receptor-type tyrosine-protein kinase FLT3, EC:2.7.10.1 , FL cytokine receptor, Fms-like tyrosine kinase 3
Accession A0A2K5VQ48
Amino Acid Sequence

Gln28-Ser541, with hIgG1 at C-terminus

Expression System HEK293
Molecular Weight

120-140 kDa (Reducing)

Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag Human Fc Tag
Physical Appearance Lyophilized Powder
Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.

·3 months, -20 to -80℃ under sterile conditions after reconstitution.

·1 week, 2 to 8℃ under sterile conditions after reconstitution.

·Please avoid repeated freeze-thaw cycles.

Background

The Flt-3 (fms-like tyrosine kinase) receptor, also named Flk-2 (fetal liver kinase) and Stk-1(stem cell tyrosine kinase) is a 130-155 kDa member of the class III subfamily of receptor tyrosine kinases that also includes KIT, the receptor for SCF and FMS, the receptor for M-CSF. The extracellular region of these receptors contains five immunoglobulin-like domains and the intracellular region contains a split kinase domain. FLT3 is a cytokine receptor which belongs to the receptor tyrosine kinase class III. Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways.

Picture

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

ELISA

Immobilized FLT-3L Protein, Human (Cat. No. UA040011) at 0.5μg/mL (100μL/well) can bind Flt-3/Flk-2 Fc Chimera Protein, Cynomolgus (Cat. No. UA040549) with EC50 of 0.43-0.96 ng/ml.